News

Thermo Fisher Scientific Inc., a global leader in scientific innovation, has unveiled the Invitrogen EVOS S1000 Spatial Imaging System. This cutting-edge system overcomes the limitations of current fluorescent microscopy by enabling researchers to produce high-quality multiplexed images of multiple samples within hours, making spatial tissue proteomics more accessible.

Part of Thermo Fisher Scientific’s advanced line of cell imaging microscopes and systems, the EVOS S1000 utilizes patented spectral technology to capture images of up to 9 different targets simultaneously. This reduces the need for multiple imaging rounds and helps maintain tissue integrity.

“Understanding tissue structure and function is crucial for developing new treatments for solid tumors and neurodegenerative diseases,” said Trisha Dowling, vice president and general manager for flow and imaging technologies at Thermo Fisher Scientific. “The EVOS S1000 delivers a detailed snapshot of tissue microenvironments and architecture in their native state, helping researchers accelerate their experiments, achieve more with their tissue samples and drive advancements in critical research areas.”

With its broad compatibility with various reagents and antibodies, the system integrates easily into existing lab workflows, addressing the growing need for multiplex imaging.

Now available commercially in the U.S. and Europe, the EVOS S1000 Spatial Imaging System equips researchers with the necessary tools to deepen their understanding of complex biological systems and foster the development of new disease treatments.

© Thermo Fisher Scientific, Inc.